Association between Nuclear Morphometry Parameters and Gleason Grade in Patients with Prostatic Cancer.
Gleason grade
cell morphometry
prostate cancer
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
31 May 2022
31 May 2022
Historique:
received:
21
04
2022
revised:
21
05
2022
accepted:
26
05
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Objective: Gleason scoring system remains the pathological method of choice for prostate cancer (Pca) grading. However, this method of tumor tissue architectural structure grading is still affected by subjective assessment and might succumb to several disadvantages, mainly inter-observer variability. These limitations might be diminished by determining characteristic cellular heterogeneity parameters which might improve Gleason scoring homogeneity. One of the quantitative tools of tumor assessment is the morphometric characterization of tumor cell nuclei. We aimed to test the relationship between various morphometric measures and the Gleason score assigned to different prostate cancer samples. Materials and Methods: We reviewed 60 prostate biopsy samples performed at a tertiary uro-oncology center. Each slide was assigned a Gleason grade according to the International Society of Urological Pathology contemporary grading system by a single experienced uro-pathologist. Samples were assigned into groups from grades 3 to 5. Next, the samples were digitally scanned (×400 magnification) and sampled on a computer using Image-Pro-Plus software©. Manual segmentation of approximately 100 selected tumor cells per sample was performed, and a computerized measurement of 54 predetermined morphometric properties of each cell nuclei was recorded. These characteristics were used to compare the pathological group grades assigned to each specimen. Results: Initially, of the 54 morphometric parameters evaluated, 38 were predictive of Gleason grade (p < 0.05). On multivariate analysis, 7 independent parameters were found to be discriminative of different Pca grades: minimum radius shape, intensity—minimal gray level, intensity—maximal gray level, character—gray level (green), character—gray level (blue), chromatin color, fractal dimension, and chromatin texture. A formula to predict the presence of Gleason grade 3 vs. grades 4 or 5 was developed (97.2% sensitivity, 100% specificity). Discussion: The suggested morphometry method based on seven selected parameters is highly sensitive and specific in predicting Gleason score ≥ 4. Since discriminating Gleason score 3 from ≥4 is essential for proper treatment selection, this method might be beneficial in addition to standard pathological tissue analysis in reducing variability among pathologists.
Identifiants
pubmed: 35741165
pii: diagnostics12061356
doi: 10.3390/diagnostics12061356
pmc: PMC9222000
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Mod Pathol. 2004 Mar;17(3):292-306
pubmed: 14976540
Anal Quant Cytol Histol. 1996 Dec;18(6):471-80
pubmed: 8978871
Cancer. 1999 Nov 15;86(10):1944-51
pubmed: 10570417
J Urol. 1988 May;139(5):1080-4
pubmed: 3361653
Cell Oncol. 2009;31(4):251-9
pubmed: 19633362
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Arch Pathol Lab Med. 2003 Aug;127(8):1007-8
pubmed: 12873176
Sci Rep. 2020 Jun 18;10(1):9911
pubmed: 32555410
Urology. 2001 Feb;57(2):291-5
pubmed: 11182339
J Urol. 1988 May;139(5):1085-90
pubmed: 3283380
J Urol. 1992 Jul;148(1):87-91
pubmed: 1613888
Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493
pubmed: 32589068
Am J Clin Pathol. 1994 Oct;102(4 Suppl 1):S38-56
pubmed: 7524306
Eur Urol. 2016 Mar;69(3):428-35
pubmed: 26166626
Br J Cancer. 2002 Nov 18;87(11):1275-80
pubmed: 12439717
Cancer Res. 2012 Oct 1;72(19):4875-82
pubmed: 23002210
Am J Surg Pathol. 2020 Aug;44(8):e87-e99
pubmed: 32459716
Asian J Androl. 2012 May;14(3):375-84
pubmed: 22504875
BJU Int. 2002 Jul;90(1):20-5
pubmed: 12081763